UCLouvain Bruxelles Woluwe, also known as Louvain-en-Woluwe or Alma, is a campus of the University of Louvain in Brussels, Belgium.

During the past decade, Ucl Bruxelles conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ucl Bruxelles" #1 collaborator was "The Lymphoma Study Association" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ucl Bruxelles" are "Arteriovenous Malformations" (1 trials), "Chronic Myeloid Leukemia" (1 trials), "Hodgkin's Lymphoma" (1 trials), "Ph+ Acute Lymphoblastic Leukemia" (1 trials) and "Rectum Cancer" (1 trials). Many other conditions were trialed in "Ucl Bruxelles" in a lesser frequency.

Most popular intervention types in "Ucl Bruxelles" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BEACOPPesc" (1 trials), "BEACOPPesc - ABVD - PET2" (1 trials), "Clinical database" (1 trials), "Ponatinib" (1 trials) and "Sirolimus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ucl Bruxelles" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ucl Bruxelles". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ucl Bruxelles, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ucl Bruxelles, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".